EYES - Second Sight Medical Products, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Second Sight Medical Products, Inc.

12744 San Fernando Road
Suite 400
Sylmar, CA 91342
United States
818-833-5000
http://www.secondsight.com

SectorHealthcare
IndustryMedical Devices
Full Time Employees123

Key Executives

NameTitlePayExercisedYear Born
Mr. Jonathan Will McGuireCEO, Pres & Director649.11kN/A1963
Mr. John T. BlakeCFO & Corp. Sec.431.96kN/A1976
Mr. William Patrick RyanChief Operating Officer384.24kN/A1961
Gunnar BjorgFounderN/AN/AN/A
Mr. Stephen D. Okland Jr.Chief Commercial OfficerN/AN/A1964
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. It also offers Argus II Retinal Prosthesis System for treating retinitis pigmentosa. The company was founded in 1998 and is headquartered in Sylmar, California.

Corporate Governance

Second Sight Medical Products, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.